Q&A: Renalytix AI Prez Explains How MCIT Rule Will Aid Kidney Product Coverage By CMS

Kidney disease. 3d illustration.
3D Illustration of kidney disease, the risk for which can be diagnosed through use of Renalytix AI’s new KidneyIntelX artificial intelligence-enabled diagnostic

More from Policy & Regulation

More from Medtech Insight